Total Payments
$14,788
2024 Payments
$1,461
Companies
48
Transactions
427
Medicare Patients
12,492
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$11,832 (80.0%)
Travel$2,926 (19.8%)
Education$29.65 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,832 | 412 | 80.0% |
| Travel and Lodging | $2,926 | 14 | 19.8% |
| Education | $29.65 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $4,057 | 69 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,795 | 53 | $0 (2020) |
| Boston Scientific Corporation | $2,299 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $931.52 | 52 | $0 (2024) |
| Amgen Inc. | $401.88 | 16 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $352.55 | 20 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $349.69 | 16 | $0 (2024) |
| PFIZER INC. | $267.22 | 16 | $0 (2023) |
| Medtronic, Inc. | $255.85 | 5 | $0 (2024) |
| Edwards Lifesciences Corporation | $255.48 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,461 | 37 | Abbott Laboratories ($638.29) |
| 2023 | $1,984 | 64 | Abbott Laboratories ($736.33) |
| 2022 | $1,012 | 43 | Boston Scientific Corporation ($285.14) |
| 2021 | $1,614 | 51 | Abbott Laboratories ($953.04) |
| 2020 | $1,640 | 45 | Abbott Laboratories ($908.27) |
| 2019 | $2,318 | 39 | Medtronic Vascular, Inc. ($1,765) |
| 2018 | $2,899 | 76 | BOSTON SCIENTIFIC CORPORATION ($1,131) |
| 2017 | $1,859 | 72 | Medtronic Vascular, Inc. ($667.58) |
All Payment Transactions
427 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $66.47 | General |
| Category: Heart Failure | ||||||
| 10/29/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Vascular | ||||||
| 10/08/2024 | Abbott Laboratories | ADVISOR (Device) | Food and Beverage | In-kind items and services | $78.74 | General |
| Category: Electrophysiology | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Boston Scientific Corporation | INGEVITY MRI (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Ingevity MRI_CRM | ||||||
| 09/04/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $45.76 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardiology | ||||||
| 07/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $107.92 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 07/23/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $119.28 | General |
| Category: Heart Failure | ||||||
| 07/19/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $39.16 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $70.21 | General |
| Category: Heart Failure | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | Abbott Laboratories | ADVISOR (Device) | Food and Beverage | In-kind items and services | $91.91 | General |
| Category: Electrophysiology | ||||||
| 06/04/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Vascular | ||||||
| 06/04/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: Vascular | ||||||
| 06/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiology | ||||||
| 05/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: DIABETES | ||||||
| 04/25/2024 | Boston Scientific Corporation | ACUITY Steerable (Device) | Food and Beverage | In-kind items and services | $108.51 | General |
| Category: ACUITY_CRM | ||||||
| 04/23/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: LUX-Dx_CRM | ||||||
| 04/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: DIABETES | ||||||
| 04/02/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 2,907 | 4,173 | $860,196 | $316,339 |
| 2022 | 31 | 3,039 | 4,311 | $853,962 | $343,293 |
| 2021 | 31 | 3,175 | 4,489 | $810,840 | $375,447 |
| 2020 | 43 | 3,371 | 4,582 | $856,462 | $343,879 |
Total Patients
12,492
Total Services
17,555
Medicare Billing
$1.4M
Procedure Codes
155
All Medicare Procedures & Services
155 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 393 | 734 | $124,200 | $45,779 | 36.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 124 | 127 | $77,162 | $43,840 | 56.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 193 | 197 | $66,068 | $29,459 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 309 | $46,394 | $28,149 | 60.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 138 | 240 | $37,440 | $22,730 | 60.7% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 118 | 130 | $21,800 | $16,533 | 75.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 83 | 348 | $34,800 | $15,589 | 44.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 89 | 92 | $31,172 | $12,902 | 41.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 97 | 177 | $21,910 | $11,161 | 50.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 77 | $22,682 | $10,693 | 47.1% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 41 | 42 | $24,036 | $8,406 | 35.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 33 | 35 | $35,180 | $6,262 | 17.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 120 | 125 | $34,854 | $6,232 | 17.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 31 | 32 | $12,740 | $6,154 | 48.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 105 | 108 | $21,681 | $5,869 | 27.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 38 | 39 | $13,110 | $5,509 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $11,524 | $4,789 | 41.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 45 | $8,967 | $4,676 | 52.1% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 27 | 27 | $10,642 | $3,422 | 32.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 243 | 292 | $14,112 | $2,932 | 20.8% |
| 75989 | Review by radiologist of image for drainage of fluid | Facility | 2023 | 45 | 58 | $29,000 | $2,580 | 8.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,405 | $2,130 | 39.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 33 | 67 | $16,700 | $1,987 | 11.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 33 | $7,361 | $1,938 | 26.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 38 | 38 | $8,810 | $1,818 | 20.6% |
About Dr. Siddhartha Acharya, MD
Dr. Siddhartha Acharya, MD is a Cardiovascular Disease healthcare provider based in Texas City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093722019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Siddhartha Acharya, MD has received a total of $14,788 in payments from pharmaceutical and medical device companies, with $1,461 received in 2024. These payments were reported across 427 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($11,832).
As a Medicare-enrolled provider, Acharya has provided services to 12,492 Medicare beneficiaries, totaling 17,555 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 155 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Texas City, TX
- Active Since 08/02/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1093722019
Products in Payments
- ClosureFast (Device) $1,678
- STINGRAY (Device) $1,088
- Advisor Catheter (Device) $943.35
- ENTRESTO (Drug) $838.84
- ADVISOR (Device) $679.37
- CoreValve Evolut (Device) $622.93
- ELIQUIS (Drug) $408.50
- LifeVest (Device) $352.55
- CARDIOMEMS (Device) $343.36
- Angio-Seal Vascular Closure Dev (Device) $333.58
- Repatha (Biological) $297.99
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $274.56
- Impella (Device) $244.47
- JARDIANCE (Drug) $240.06
- HawkOne (Device) $228.16
- VERQUVO (Drug) $222.52
- LUX-Dx Insertable Cardiac Monitor (Device) $205.77
- XARELTO (Drug) $191.65
- NEXLETOL (Drug) $186.25
- AMPLATZER Occluders (Device) $174.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.